IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

HARARI, SERGIO ALFONSO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 11.631
NA - Nord America 11.087
EU - Europa 10.321
SA - Sud America 1.485
AF - Africa 258
OC - Oceania 66
Continente sconosciuto - Info sul continente non disponibili 4
Totale 34.852
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.598
CN - Cina 3.838
SG - Singapore 3.514
IT - Italia 2.889
DE - Germania 2.180
HK - Hong Kong 1.190
BR - Brasile 1.146
GB - Regno Unito 1.064
RU - Federazione Russa 1.004
VN - Vietnam 899
SE - Svezia 673
FR - Francia 615
IN - India 440
IE - Irlanda 425
NL - Olanda 385
BD - Bangladesh 381
CA - Canada 319
ID - Indonesia 318
FI - Finlandia 266
JP - Giappone 216
ES - Italia 203
TR - Turchia 201
KR - Corea 145
AR - Argentina 127
MX - Messico 95
AT - Austria 81
CI - Costa d'Avorio 75
UA - Ucraina 74
PL - Polonia 73
IQ - Iraq 66
CH - Svizzera 63
AU - Australia 57
TH - Thailandia 56
PH - Filippine 54
CO - Colombia 51
EC - Ecuador 51
ZA - Sudafrica 51
TW - Taiwan 45
DK - Danimarca 43
CL - Cile 41
BE - Belgio 38
PT - Portogallo 37
GR - Grecia 33
PK - Pakistan 33
UZ - Uzbekistan 28
AE - Emirati Arabi Uniti 26
EG - Egitto 24
MY - Malesia 24
PY - Paraguay 23
SA - Arabia Saudita 23
RO - Romania 22
CZ - Repubblica Ceca 20
MA - Marocco 20
TN - Tunisia 19
LU - Lussemburgo 18
NO - Norvegia 18
IL - Israele 17
IR - Iran 17
CR - Costa Rica 16
DZ - Algeria 15
EU - Europa 15
VE - Venezuela 15
ET - Etiopia 14
NP - Nepal 14
HN - Honduras 13
JO - Giordania 13
KE - Kenya 13
AZ - Azerbaigian 12
LB - Libano 12
LT - Lituania 12
UY - Uruguay 12
HR - Croazia 11
HU - Ungheria 11
PE - Perù 11
AL - Albania 10
JM - Giamaica 10
LV - Lettonia 9
NZ - Nuova Zelanda 9
BY - Bielorussia 7
NG - Nigeria 7
NI - Nicaragua 7
PS - Palestinian Territory 7
SI - Slovenia 7
BG - Bulgaria 6
BO - Bolivia 6
GT - Guatemala 6
KZ - Kazakistan 6
DO - Repubblica Dominicana 5
EE - Estonia 5
KW - Kuwait 5
TT - Trinidad e Tobago 5
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
KG - Kirghizistan 4
LA - Repubblica Popolare Democratica del Laos 4
LK - Sri Lanka 4
RS - Serbia 4
SC - Seychelles 4
SV - El Salvador 4
AO - Angola 3
Totale 34.813
Salva come PNG Salva come JPEG
Città #
Singapore 1.919
Ashburn 1.263
Frankfurt am Main 1.250
Hong Kong 1.062
Dallas 903
San Jose 756
Southend 727
Milan 704
Fairfield 533
Chandler 455
Beijing 436
Dublin 419
Council Bluffs 416
Hanover 415
Princeton 401
Los Angeles 389
Hefei 340
Ho Chi Minh City 259
Wilmington 259
Seattle 256
New York 246
Santa Clara 242
Lauterbourg 240
Jakarta 223
Houston 215
Boardman 214
Hanoi 213
Woodbridge 212
Guangzhou 203
Buffalo 199
Rome 190
Cambridge 184
Helsinki 184
Moscow 177
Bengaluru 176
Des Moines 160
Chicago 156
Shanghai 139
Ann Arbor 136
Munich 106
São Paulo 104
Istanbul 99
Tokyo 99
Naples 95
Toronto 93
Cangzhou 92
Tianjin 82
Abidjan 75
Nuremberg 74
The Dalles 72
Madrid 71
Bologna 70
Seoul 70
Shenzhen 66
Chengdu 63
London 62
Nanjing 61
Redwood City 61
Beauharnois 58
Montreal 56
Salt Lake City 55
San Diego 54
Genoa 52
Phoenix 52
Atlanta 51
Florence 46
Shenyang 45
Warsaw 45
Da Nang 44
Jinan 44
Paris 43
Columbus 42
Lappeenranta 42
Amsterdam 39
Hangzhou 39
Rio de Janeiro 39
Grafing 38
Haiphong 37
Turin 37
Elk Grove Village 36
Jacksonville 35
Washington 35
Palermo 34
Denver 33
Berlin 32
Dong Ket 32
Stockholm 32
Vienna 32
Bangkok 31
Changsha 31
Rho 30
Zhengzhou 30
Brooklyn 29
Eitensheim 29
Mexico City 28
Orem 28
Roxbury 28
Wuhan 28
Glasgow 27
Mumbai 27
Totale 19.991
Salva come PNG Salva come JPEG
Nome #
Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation : A systematic review and meta-Analysis of 4,200,000 patients 949
Malattie interstiziali polmonari 545
An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms 508
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 453
Novel evidence for a greater burden of ambient air pollution on cardiovascular disease 414
LINE1 are spliced in non-canonical transcript variants to regulate T cell quiescence and exhaustion 388
Coexpression of ΔNp63/p40 and TTF1 Within Most of the Same Individual Cells Identifies Life-Threatening NSCLC Featuring Squamous and Glandular Biphenotypic Differentiation: Clinicopathologic Correlations 383
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis 361
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 356
Polmonite organizzativa criptogenetica: L'essenziale da sapere 350
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 346
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 346
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 340
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 323
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 321
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone 318
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial 293
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 283
Trattamento videotoracoscopico dell'enfisema polmonare 267
Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal 267
Comorbidities in idiopathic pulmonary fibrosis : an underestimated issue 266
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study 262
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 252
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 250
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 247
Everolimus for the treatment of lymphangioleiomyomatosis: A phase II study 237
Routine surgical videothoracoscopy as the first step of the planned resection for lung cancer 235
Pulmonary hypertension associated with lung diseases 231
Spread of hyperplastic pulmonary neuroendocrine cells into air spaces (S.H.I.P.M.E.N.T.S) : a proof for artifact 230
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia 223
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards : data from the RePoSI Registry 221
Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models 220
Clinical implications of lung neuroendocrine neoplasm classification 217
Toupet fundoplication to prevent progression of scleroderma-associated interstitial lung damage: a study protocol 214
The association between air pollution and the incidence of idiopathic pulmonary fibrosis in Northern Italy 212
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy : comment 212
PREVALENCE OF COPD IN A LUNG CANCER SCREENING PROGRAM WITH LOW DOSE CT SCAN 204
Giant Secondary Overgrowth of Type-1 Pulmonary Cystic Airway Malformation Upon Development of Anaplastic Lymphoma Kinase–Rearranged Adenocarcinoma 201
Pulmonary hypertension in chronic lung disease and hypoxia 200
European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis 199
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases 198
Recent advances in the molecular landscape of lung neuroendocrine tumors 198
Pulmonary hypertension and chronic lung disease : where are we headed? 198
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: An international case-cohort study 194
Clinical course of IPF in Italian patients during 12 months of observation : results from the FIBRONET observational study 194
High-resolution CT in smoking-related interstitial lung diseases 193
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 192
Classification of pulmonary neuroendocrine tumors: New insights 191
The diagnosis of cystic lung diseases: A role for bronchoalveolar lavage and transbronchial biospy? 188
Epidemiology of idiopathic pulmonary fibrosis in northern Italy 187
Randomized Phase II Trial of Inhaled Budesonide versus Placebo in High-Risk Individuals with CT Screen–Detected Lung Nodules 181
Lung cryobiopsy for the diagnosis of interstitial lung diseases: A series contribution to a debated procedure 179
Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis 178
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards : data from the RePoSI Registry 178
Coronary artery calcium score is a prognostic factor for mortality in idiopathic pulmonary fibrosis 177
Idiopathic pulmonary fibrosis and sleep disorders: No longer strangers in the night 175
The International LAM Registry: A component of an innovative web-based clinician, researcher, and patient-driven rare disease research platform 173
Evolution of emphysema in relation to smoking 172
Surfactant derived protein type B: a new biomarker linked to respiratory failure and lung damage in mild to moderate SARS-CoV-2 pneumonia 171
MTOR inhibitors and risk of ovarian cysts : A systematic review and meta-analysis 171
Fibrosing interstitial lung diseases : knowns and unknowns 170
Prognostic value of pulmonary hypertension in patients with chronic interstitial lung disease referred for lung or heart-lung transplantation 166
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for {COVID}-19: comment 163
Rare pulmonary diseases and orphan drugs: Where do we stand and where are we going to? 159
Rejection and nonrejection related forms of bronchiolitis obliterans: Morphologic terms or clinico-pathological entities? 159
Randomised controlled trials and real-life studies : two answers for one question 155
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study 154
Pulmonary Langerhans Cell Histiocytosis and Lymphangioleiomyomatosis Have Circulating Cells With Loss of Heterozygosity of the TSC2 Gene 153
Lung function predicts lung cancer risk in smokers : a tool for targeting screening programs 153
Diffuse cystic lung diseases : correlation between radiologic and functional status 151
Proliferating cell nuclear antigen immunostaining of the endothelial cells in lung transplantation 151
Airway inflammation in severe chronic obstructive pulmonary disease: Relationship with lung function and radiologic emphysema 151
Recent advances and current controversies in lung neuroendocrine neoplasms✰ 151
Identification of Lymphangioleiomyomatosis-associated Serum MicroRNAs 149
Cellular interactions in the pathogenesis of interstitial lung diseases 149
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: analysis of the REPOSI registry 147
The usefulness of D-dimer as a predictive marker for mortality in patients with COVID-19 hospitalized during the first wave in Italy 146
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 146
Impact of the post-COVID-19 condition on health care after the first disease wave in Lombardy 145
Vaccination Strategies in Respiratory Diseases: Recommendation from AIPO-ITS/ETS, SIMIT, SIP/IRS, and SItI 145
Improving survival in lymphangioleio-myomatosis : a 16-year observational study in a large cohort of patients 145
Nintedanib for patients with lymphangioleiomyomatosis: a phase 2, open-label, single-arm study 144
Terbinafina: Un nuovo farmaco antimicotico nel trattamento dell'aspergillosi polmonare : Studio pilota 140
Absence of hyperhomocysteinemia in ten patients with primary pulmonary hypertension 138
Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells 138
Making the case for causality : what role do lung microbiota play in idiopathic pulmonary fibrosis? 138
Morphologic and molecular classification of lung neuroendocrine neoplasms 138
Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach 137
A 69-year-old female with multiple, bilateral pulmonary nodules 137
Symptomatic post COVID patients have impaired alveolar capillary membrane function and high VE/VCO2 136
Fibrotic interstitial lung diseases and air pollution : a systematic literature review 136
Charlson comorbidity index, neutrophil-to-lymphocyte ratio and undertreatment with renin-angiotensin-aldosterone system inhibitors predict in-hospital mortality of hospitalized COVID-19 patients during the omicron dominant period 135
The heterogeneity of lung involvement in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome: a case of hypersensitivity pneumonitis-like pattern 133
Early infections and bronchiolitis obliterans-organizing pneumonia in single lung transplant recipients 132
Significant functional improvement in IPF patient treated with antifibrotic drugs: preliminary results and clinical outcome 131
Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study – Rationale and study design 131
Beyond idiopathic pulmonary fibrosis : the world of progressive-fibrosing interstitial lung disease 131
Immunocytochemical detection of progesterone receptors. A study in a patient with primary pulmonary hypertension 130
RISE-IIP : some pitfalls and observations 130
Bronchoscopic diagnosis of Langerhans cell histiocytosis and lymphangioleiomyomatosis 127
Totale 21.802
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.684
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021397 0 0 0 0 0 0 0 0 0 0 118 279
2021/20222.606 117 109 108 163 193 194 168 224 294 260 202 574
2022/20232.870 341 236 255 328 204 528 114 161 292 64 259 88
2023/20243.182 127 152 136 202 550 203 231 212 175 266 438 490
2024/20257.682 406 885 270 729 470 367 412 658 448 654 732 1.651
2025/202615.450 1.285 1.406 1.849 1.495 1.477 1.037 2.047 1.005 1.675 980 1.194 0
Totale 36.099